GlaxoSmithKline: Thrombocytopenia trials

The registry lists 21 Thrombocytopenia studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 1 5Phase 2 6Phase 3 4Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected PatientsCompletedNCT01636778Phase 2Results posted
• Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.CompletedNCT01520909Phase 3Results posted
• Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type IICompletedNCT01304238Results posted
• Safety and Efficacy Study for Solid Tumor Patients Treated With EltrombopagCompletedNCT01147809Phase 2Results posted
• Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390CompletedNCT00996216Phase 3Results posted
• Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00908037Phase 2Results posted
• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresTerminatedNCT00678587Phase 3Results posted
• Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)CompletedNCT00424177Phase 2Results posted
• RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With EltrombopagCompletedNCT00370331Phase 3Results posted
• Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult SubjectsCompletedNCT01657552Phase 1
• WEUSKOP5410: Observational Study in ENABLE Clinical TrialsCompletedNCT01458080
• Indirect Comparison Between Eltrombopag & RomiplostimCompletedNCT01236014
• Meta-analysis - EltrombopagCompletedNCT01235988
• Promacta Pregnancy RegistryCompletedNCT01064336
• Milk-only Lactation Study for Patients on EltrombopagWithdrawnNCT01055600Phase 4
• Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)CompletedNCT00903422Phase 1
• Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal ImpairmentCompletedNCT00442871Phase 1
• Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic ImpairmentCompletedNCT00359463Phase 1
• Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And IfosfamideCompletedNCT00358540Phase 1
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis CCompletedNCT00110799Phase 2
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving ChemotherapyCompletedNCT00102726Phase 2